2026-01-26 - Analysis Report
**1. Company Overview**
D-Wave Quantum Technology Inc. is a leading developer of quantum computers.

**2. Return Rate Comparison**

* Cumulative Return of Review Stock: 991.26%
* Cumulative Return of Comparison Stock (S&P 500, VOO): 77.84%
* Divergence (max: 1843.90, min: -104.90, current: 925.00, relative divergence: 52.80%)

The review stock has a high cumulative return rate, significantly higher than the comparison stock. The divergence is at its current value of 925.00, which indicates a relative divergence of 52.80%.

**3. Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2021-2023  | -64.0% | 89.3% | -84.0% | 0.7 | 0.3B |
| 2022-2024  | 322.0% | 89.3% | 292.0% | 1.1 | 3.1B |
| 2023-2025  | 1097.0% | 74.4% | 1022.0% | 2.7 | 9.7B |

The review stock had a high Alpha value in 2023-2025, indicating a high return relative to the market. The Beta value also increased significantly, indicating increased volatility.

**4. Recent Stock Price Fluctuations**

* Close: $25.63 
* Last-market: $25.63 (price), $27.43 (previous Close), -$6.56 (change)
* 5-day SMA: $26.99
* 20-day SMA: $28.02
* 60-day SMA: $27.21

The review stock's price has decreased in the last market, with a sharp decline of -$6.56. The 5-day and 20-day SMA are higher than the current price, indicating a potential rebound.

**5. RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence, Expected_Return**

* Market Risk Indicator (MRI): 0.70 (High Investment Recommended: 0.9~1.0, Medium Investment: 0.7~0.9)
* RSI: 42.12
* PPO: -1.45
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: -6.80 (-): worsening
* 7-day Rank change: 0 (0): flat
* 7-day Dynamic Expected Return change: 0.00 (0): flat
* Expected Return (%): 11.90%

The review stock's MRI is at the medium investment level, indicating a moderate level of risk. The RSI is at a low value of 42.12, indicating an oversold condition. The PPO is also at a low value, indicating a potential buy signal.

**6. Recent News & Significant Events**

Based on the provided news headlines, there are some positive developments, such as:
- Needham’s Top Analyst Says, ‘D-Wave Gains Edge via Circuits Buy’
- Rosenblatt Lifts PT on D-Wave Quantum (QBTS) Stock
However, there are also some negative developments, such as:
- How Low Can QBTS Stock Go?
- Prediction: D-Wave Quantum Stock Will Be Worth This Much by Year-End 2026 (note: this is a prediction and not a guarantee)

**7. Analyst Opinions**

Analyst Consensus:
- Key: Strong_Buy
- Mean (1=StrongBuy~5=Sell): 1.40 (~Strong Buy)
- Opinions: 15
- Target Price (avg/high/low): 38.70 / 48.00 / 22.54

The analyst consensus is strong buy, with a mean rating of 1.40 and 15 opinions. The target price range is between $22.54 and $48.00.

**8. Recent Earnings Analysis**

| Date | EPS | Revenue |
|-----|------|---------|
| 2025-11-06 | -0.41 | $0.00 B |
| 2025-08-07 | -0.55 | $0.00 B |
| 2025-05-08 | -0.02 | $0.02 B |
| 2024-11-14 | -0.11 | $0.00 B |
| 2025-11-06 | -0.11 | $0.00 B |

The review stock has reported negative earnings per share (EPS) for the past several quarters, with some volatility. However, the revenue figures are zero for most quarters, indicating a lack of significant revenue growth.

**9. Financial Information**

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $0.00B | 71.38% |
| 2025-06-30 | $0.00B | 63.84% |
| 2025-03-31 | $0.02B | 92.51% |
| 2024-12-31 | $0.00B | 63.79% |
| 2024-09-30 | $0.00B | 55.78% |

The review stock has reported some volatility in revenue, with $0.00B for most quarters. However, the profit margin has been increasing in some quarters.

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $0.67B | -20.88% |
| 2025-06-30 | $0.69B | -24.10% |
| 2025-03-31 | $0.21B | -2.61% |
| 2024-12-31 | $0.06B | -137.40% |
| 2024-09-30 | $-0.02B | 134.27% |

The review stock's equity has been fluctuating between positive and negative values. The return on equity (ROE) has been negative for most quarters, indicating low profitability.

**10. Comprehensive Analysis**

Based on the analysis above, the review stock has had a high cumulative return rate, with significant volatility. The analyst consensus is strong buy, and the target price range is between $22.54 and $48.00. However, the earnings per share (EPS) has been negative, and the revenue figures are zero for most quarters, indicating a lack of significant revenue growth. The financial information shows some volatility in revenue and profitability.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.